Nature Medicine Journal

Overview
Identity
View All

publication venue for

Global, regional and national burden of dietary iron deficiency from 1990 to 2021: a Global Burden of Disease study.. 1-21. 2025
Liberal fluid intake versus fluid restriction in chronic heart failure: a randomized clinical trial.. 1-7. 2025
Artificial intelligence for direct-to-physician reporting of ambulatory electrocardiography.. 31:925-931. 2025
How to make cardiology clinical trials more inclusive.. 30:2745-2755. 2024
Targeting axonal guidance dependencies in glioblastoma with ROBO1 CAR T cells. 30:2936-2946. 2024
The argument framework is a flexible approach to evidence in healthcare. 30:2113-2116. 2024
A global initiative to deliver precision health in diabetes. 30:1819-1822. 2024
Risk-based lung cancer screening performance in a universal healthcare setting. 30:1054-1064. 2024
Clonal hematopoiesis of indeterminate potential is associated with acute kidney injury. 30:810-817. 2024
Interventions to enhance digital health equity in cardiovascular care. 30:628-630. 2024
Publisher Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis. 30:910-910. 2024
Anticoagulation with osocimab in patients with kidney failure undergoing hemodialysis: a randomized phase 2 trial. 30:435-442. 2024
Belantamab mafodotin, pomalidomide and dexamethasone in refractory multiple myeloma: a phase 1/2 trial. 30:543-551. 2024
Author Correction: Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis. 29:3268-3268. 2023
Benefits and harms of cervical screening, triage and treatment strategies in women living with HIV. 29:3059-3066. 2023
Benefits, harms and cost-effectiveness of cervical screening, triage and treatment strategies for women in the general population. 29:3050-3058. 2023
Reporting standards for the use of large language model-linked chatbots for health advice. 29:2988-2988. 2023
Thymus alterations and susceptibility to immune checkpoint inhibitor myocarditis. 29:3100-3110. 2023
Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine. 29:2438-2457. 2023
ctDNA response after pembrolizumab in non-small cell lung cancer: phase 2 adaptive trial results. 29:2559-2569. 2023
The Aging Biomarker Consortium represents a new era for aging research in China. 29:2162-2165. 2023
Pregnant and lactating women should be included in clinical trials for cardiovascular disease. 29:1897-1899. 2023
Association of wearable device-measured vigorous intermittent lifestyle physical activity with mortality. 28:2521-2529. 2022
Human pluripotent stem-cell-derived islets ameliorate diabetes in non-human primates. 28:272-282. 2022
Author Correction: Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial. 28:212-212. 2022
Reply to: Concerns about estimating relative risk of death associated with convalescent plasma for COVID-19. 28:53-58. 2022
Convalescent plasma for hospitalized patients with COVID-19: an open-label, randomized controlled trial. 27:2012-2024. 2021
Anemia prevalence in women of reproductive age in low- and middle-income countries between 2000 and 2018. 27:1761-1782. 2021
COVID-19 boosters in rich nations will delay vaccines for all. 27:1659-1660. 2021
Can space-based technologies help manage and prevent pandemics?. 27:1489-1490. 2021
Childhood amyotrophic lateral sclerosis caused by excess sphingolipid synthesis. 27:1197-1204. 2021
Author Correction: Placebo use and unblinding in COVID-19 vaccine trials: recommendations of a WHO Expert Working Group. 27:925-925. 2021
Placebo use and unblinding in COVID-19 vaccine trials: recommendations of a WHO Expert Working Group. 27:569-570. 2021
COVID-19 clinical trials: learning from exceptions in the research chaos.. 26:1671-1672. 2020
Author Correction: Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017. 26:1308-1308. 2020
Modeling shield immunity to reduce COVID-19 epidemic spread. 26:849-854. 2020
Mapping local patterns of childhood overweight and wasting in low- and middle-income countries between 2000 and 2017. 26:750-759. 2020
Deciphering brain tumor heterogeneity, one cell at a time. 25:1474-1476. 2019
Genome-wide germline correlates of the epigenetic landscape of prostate cancer. 25:1615-1626. 2019
Bacteria to alleviate metabolic syndrome. 25:1031-1033. 2019
Author Correction: Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo. 25:526-528. 2019
Metformin inhibits gluconeogenesis via a redox-dependent mechanism in vivo. 24:1384-1394. 2018
An AMP-activated protein kinase–stabilizing peptide ameliorates adipose tissue wasting in cancer cachexia in mice. 22:1120-1130. 2016
Duodenal energy sensing regulates hepatic glucose output. 21:428-429. 2015
Reciprocal cellular cross-talk within the tumor microenvironment promotes oncolytic virus activity. 21:530-536. 2015
Inhibiting peripheral serotonin synthesis reduces obesity and metabolic dysfunction by promoting brown adipose tissue thermogenesis. 21:166-172. 2015
Whole-genome sequencing of quartet families with autism spectrum disorder. 21:185-191. 2015
Rescue of Hippo coactivator YAP1 triggers DNA damage–induced apoptosis in hematological cancers. 20:599-606. 2014
Single phosphorylation sites in Acc1 and Acc2 regulate lipid homeostasis and the insulin-sensitizing effects of metformin. 19:1649-1654. 2013
How antibiotics kill bacteria: new models needed?. 19:544-545. 2013
Randomized dose-finding clinical trial of oncolytic immunotherapeutic vaccinia JX-594 in liver cancer. 19:329-336. 2013
Genetically determined P2X7 receptor pore formation regulates variability in chronic pain sensitivity. 18:595-599. 2012
Stem cell gene expression programs influence clinical outcome in human leukemia. 17:1086-1093. 2011
The transcription factor cyclic AMP–responsive element–binding protein H regulates triglyceride metabolism. 17:812-815. 2011
Normalization of obesity-associated insulin resistance through immunotherapy. 15:921-929. 2009
State of clinical research ethics in Pakistan. 13:1011-1011. 2007
A GABAergic system in airway epithelium is essential for mucus overproduction in asthma. 13:862-867. 2007
Complement targeting of nonhuman sialic acid does not mediate cell death of human embryonic stem cells. 12:1113-1114. 2006
Targeting of CD44 eradicates human acute myeloid leukemic stem cells. 12:1167-1174. 2006
CNTF reverses obesity-induced insulin resistance by activating skeletal muscle AMPK. 12:541-548. 2006
Glycogen synthase kinase-3 is an in vivo regulator of hematopoietic stem cell repopulation. 12:89-98. 2006
Peptide-based therapeutic vaccines for allergic and autoimmune diseases. 11:S69-S76. 2005
Vaccines in the public eye. 11:S20-S24. 2005
Cell encapsulation: Promise and progress. 9:104-107. 2003
Real-time in vivo imaging of platelets, tissue factor and fibrin during arterial thrombus formation in the mouse. 8:1175-1180. 2002
Multi-pronged inhibition of airway hyper-responsiveness and inflammation by lipoxin A4. 8:1018-1023. 2002
Exploiting tumor-specific defects in the interferon pathway with a previously unknown oncolytic virus. 6:821-825. 2000
The role of CD4+ lymphocytes in the susceptibility of mice to stress-induced reactivation of experimental colitis. 5:1178-1182. 1999
A newly discovered class of human hematopoietic cells with SCID-repopulating activity. 4:1038-1045. 1998
Interstitial cells of Cajal generate a rhythmic pacemaker current. 4:848-851. 1998
Errata. 3:93-93. 1997
Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy (vol 2, pg 1329, 1996). 3:93-93. 1997
Identification of primitive human hematopoietic cells capable of repopulating NOD/SCID mouse bone marrow: Implications for gene therapy. 2:1329-1337. 1996

has subject area

11 Medical and Health Sciences (FoR)
Immunology (Science Metrix)